May 19, 2020 / 8:27 PM / 8 days ago

BRIEF-Cue Biopharma Reports Qtrly Loss Per Share Of $0.48

May 19 (Reuters) - Cue Biopharma Inc:

* CUE BIOPHARMA REPORTS FIRST QUARTER 2020 RESULTS, UPDATES OF CUE-101 PHASE 1 DOSE ESCALATION STUDY AND RECENT BUSINESS HIGHLIGHTS

* CUE BIOPHARMA INC- QTRLY LOSS PER SHARE $0.48 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below